Vasogen
Investor Relations
About UsProducts in DevelopmentClinical TrialsInvestor RelationsPress ReleasesCareers

Our focus has been on the research and commercial development of therapies designed to target the destructive inflammatory process associated with the development and progression of cardiovascular and neuro-inflammatory disorders. We are not currently advancing the development of our products and are focused on exploring strategic options that may include a sale of the Company, a merger, an acquisition by us, or other strategic alternative.


 2009 Annual and Special Meeting of Shareholders
 Corporate Governance
 Annual Reports
 Quarterly Reports
 Regulatory Filings
 Corporate Calendar
 Corporate Information
 Analyst Coverage
 Information Request

      © Vasogen Inc. 2009. Legal Notice | Privacy Policy  Home    Contact Us    Search    Site Map    Printable Page